¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mitochondrial intermediate peptidase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹éÁú
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • intermediate ganglion
    Áß°£½Å°æÀý
  • intermediate host
    Áß°£¼÷ÁÖ
  • intermediate inheritance
    Áß°£À¯Àü
  • intermediate mesoderm
    Áß°£Á߹迱
  • intermediate nerve
    Áß°£½Å°æ
  • intermediate product
    Áß°£»ê¹°
  • intermediate ray
    Áß°£¹æ»ç¼±
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermediate trait
    Áß°£¼ºÇâ(¼ÒÁú)
  • intermediate-acting insulin
    Áß°£ÀÛ¿ëÀν¶¸°
  • reactive intermediate
    ¹ÝÀÀÁß°£¹°Áú
  • replicative intermediate
    º¹Á¦Áß°£»ê¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intermediate inheritance
    Áß°£À¯Àü
  • intermediate mesoderm
    Áß°£Á߹迱
  • intermediate nephron
    Áß°£ÄáÆÏ´ÜÀ§
  • intermediate nerve
    Áß°£½Å°æ
  • intermediate product
    Áß°£»ê¹°, Áß°£´ë»ç¹°
  • intermediate ray
    Áß°£¹æ»ç¼±
  • intermediate reaction
    Áß°£¹ÝÀÀ
  • intermediate spermatogonium
    Áß°£Á¤Á¶¼¼Æ÷
  • intermediate variable
    Áß°£º¯¼ö
  • intermediate density lipoprotein
    Á߹еµÁöÁú´Ü¹é
  • intermediate cell mass
    Áß°£¼¼Æ÷µ¢ÀÌ
  • intermediate field magnetic resonance scanner
    ÁßµîÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • reactive intermediate
    ¹ÝÀÀÁß°£¹°Áú
  • replicative intermediate
    º¹Á¦Áß°£»ê¹°
  • posterior intermediate sulcus
    µÚÁß°£°í¶û
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mitochondrial encephalomyopathy
    »ç¸³Ã¼¼º ³ú±Ùº´Áõ(¡­àõ ÒàÐÉÜ»ñø)
  • mitochondrial filament
    »ç¸³Ã¼¹Ì¼¼¼¶À¯
  • mitochondrial granule
    »ç¸³Ã¼°ú¸³(Þêí£ô÷Ψí£).
  • mitochondrial granule
    »ç¸³Ã¼°ú¸³
  • mitochondrial inclusion
    »ç¸³Ã¼Æ÷ÇÔ¹°
  • mitochondrial matrix
    »ç¸³Ã¼±âÁú(Þêí£ô÷Ðñòõ).
  • mitochondrial matrix
    »ç¸³Ã¼¹ÙÅÁÁú
  • mitochondrial membrane
    »ç¸³Ã¼¸·(¡­Ø¯).
  • mitochondrial membrane
    »ç¸³Ã¼¸·
  • mitochondrial myopathies
    »ç¸³Ã¼¼º ±Ùº´Áõ
  • mitochondrial sheath
    »ç¸³Ã¼Áý, »ç¸³Ã¼ÃÊ(¡­ôú).
  • mitochondrial sheath
    »ç¸³Ã¼Áý
  • parking-lot inclusions, mitochondrial myopathy
    ÁÖÂ÷ÀåÇüºÀÀÔü, »ç¸³Ã¼±Ùº´Áõ
  • central intermediate substance
    Áß½ÉÁß°£È¸»öÁú
  • gigantocellular intermediate reticular nucleus
    °Å´ë¼¼Æ÷Áß°£±×¹°ÇÙ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Inferior pontine intermediate reticular nuleus
    ¾Æ·¡´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] Çϱ³³úÁß°£¸Á»óüÇÙ
  • Superior pontine intermediate reticular nucleus
    À§´Ù¸®³úÁß°£±×¹°ÇÙ
    [¿¾ ¿ë¾î] »ó±³³úÁß°£¸Á»óüÇÙ
  • Intermediate
    Áß°£
    [¿¾ ¿ë¾î] Áß°£
  • Intermediate branch
    Áß°£°¡Áö
    [¿¾ ¿ë¾î] Áß°£Áö
  • Intermediate hepatic veins
    Áß°£°£Á¤¸Æ
    [¿¾ ¿ë¾î] Áß°£Á¤¸Æ
  • Intermediate zone
    Áß°£±¸¿ª
    [¿¾ ¿ë¾î] Áß°£´ë
  • Intermediate line
    Áß°£´É¼±
    [¿¾ ¿ë¾î] Áß°£¼±
  • Intermediate lymph nodes
    Áß°£¸²ÇÁÀý
    [¿¾ ¿ë¾î] Áß°£ÀÓÆÄÀý
  • Intermediate cervical septum
    Áß°£¸ñ»çÀ̸·
    [¿¾ ¿ë¾î] Áß°£°æºÎÁß°Ý
  • Intermediate dorsal cutaneous nerve
    Áß°£¹ßµîÇǺνŰæ
    [¿¾ ¿ë¾î] ÁßÁ·¹èÇǽŰæ
  • Intermediate ventral nucleus
    Áß°£¹èÂÊÇÙ
    [¿¾ ¿ë¾î] Áß°£º¹ÃøÇÙ
  • Intermediate part
    Áß°£ºÎºÐ
    [¿¾ ¿ë¾î] Áß°£ºÎ
  • Intermediate part [Red part]
    Áß°£ºÎºÐ
    [¿¾ ¿ë¾î] Áß°£ºÎ
  • Intermediate supraclavicular nerves
    Áß°£ºøÀåÀ§½Å°æ
    [¿¾ ¿ë¾î] Áß°£¼â°ñ»ó½Å°æ
  • Intermediate body
    Áß°£¼Òü
    [¿¾ ¿ë¾î] Áß°£¼Òü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
Pep peptidase
PEPA peptidase A
PEPB peptidase B
PEPC peptidase C
PEPD peptidase D
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DPPI Dipeptidyl peptidase I
DPP II Dipeptidyl peptidase II
SPase Signal peptidase
TPP I Tripeptidyl peptidase I
AMA Anti-mitochondrial antibodies
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
mitochondrial swelling Increase in volume of mitochondria due to an influx of fluid; it occurs in hypotonic solutions due to osmotic pressure and in isotonic solutions as a result of altered permeability of the membranes of respiring mitochondria.
(12 Dec 1998)
disease, mitochondrial Mutations (changes) in the mitochondrial chromosome are responsible for a number of disorders including an eye disease (Leber's hereditary optic atrophy), a type of epilepsy (called MERRF which stands for Myoclonus Epilepsy with Ragged Red Fibres), and a cause of dementia (called MELAS for Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-like episodes). All mitochondrial diseases were entirely enigmatic before it was discovered that they were due to mutations not in regular chromosomes but the mitochondrial chromosome.
(12 Dec 1998)
DNA, mitochondrial Double-stranded DNA of mitochondria. In eukaryotes, the mitochondrial genome is circular and codes for ribosomal rnas, transfer rnas, and about 10 proteins.
(12 Dec 1998)
alkaline D-peptidase <enzyme> A penicillin-recognizing enzyme from bacillus cereus; has beta-lactamase activity; genbank d86380
Registry number: EC 3.4.99.-
Synonym: ADP gene product, alkaline d-stereospecific endopeptidase
(26 Jun 1999)
aspartyllysine peptidase <enzyme> From human intestinal brush border; stabilised by zn+2
Registry number: EC 3.4.13.-
Synonym: zn-stable aspartyllysine peptidase
(26 Jun 1999)
C5a peptidase <enzyme> Streptococcus pyogenes enzyme inactivates complement 5a by cleaving at lysine 68, removing a six-amino acid fragment
Pharmacological action: complement inactivators
Registry number: EC 3.4.99.-
Synonym: streptococcus c5a peptidase, gbs c5a-ase, group b streptococci c5a-ase, scpa protein
(26 Jun 1999)
matrix processing peptidase <enzyme> From matrix fraction of rat liver mitochondria; cleaves mitochondrial protein precursors; inhibited by metal chelators and reactived by mn2+; classified as EC 3.4.24.64
Registry number: EC 3.4.24.-
Synonym: mitochondrial processing peptidase, mitochondrial processing protease, alpha-mpp, beta-mpp, p-52 protein, rat, p-55 protein, rat, mas1 protein, yeast, mas2 protein, yeast
(26 Jun 1999)
peptidase <enzyme> Alternative name for a protease.
(18 Nov 1997)
peptidase D <enzyme> An enzyme cleaving aminoacyl-l-proline bonds in dipeptides containing a C-terminal prolyl residue; a deficiency of this enzyme results in hyperimidodipeptiduria.
Synonym: imidodipeptidase, peptidase D, prolidase.
(05 Mar 2000)
peptidase P <enzyme> A hydrolase cleaving C-terminal dipeptides from a variety of substrates, including angiotensin I, which is converted to angiotensin II and histidylleucine.
An important step in the metabolism of certain vasopressor agents.
It is a chloride-dependent, zinc glycoprotein that is generally membrane-bound and active at neutral pH. Only single dipeptides are released from angiotensin I and bradykinin because of the lack of activity on bonds involving proline. It may also have endopeptidase activity on some substrates.
Registry number: EC 3.4.15.1
Synonym: carboxycathepsin, dipeptidyl carboxypeptidase, kinase II, peptidase P.
(22 Sep 2002)
procollagen peptidase <enzyme> The proteases that remove the terminal extension peptides of procollagen, deficiency of these enzymes leads to dermatosparaxis or Ehlers Danlos syndrome.
(18 Nov 1997)
pyroglutamyl-peptidase I <enzyme> An enzyme that catalyses the release of a n-terminal pyroglutamyl group from a polypeptide provided the next residue is not proline. It is inhibited by thiol-blocking reagents and occurs in mammalian tissues, microorganisms, and plants.
Registry number: EC 3.4.19.3
(12 Dec 1998)
PZ-PLGPA peptidase <enzyme> Endopeptidase from treponema denticola
Registry number: EC 3.4.21.-
(26 Jun 1999)
signal peptidase A peptide present on proteins that are destined either to be secreted or to be membrane components. It is usually at the N terminus and normally absent from the mature protein. Normally refers to the sequence (ca 20 amino acids) that interacts with signal recognition particle and directs the ribosome to the endoplasmic reticulum where co translational insertion takes place. Could also refer to sequences that direct post translational uptake by organelles. Signal peptides are highly hydrophobic but with some positively charged residues. The signal sequence is normally removed from the growing peptide chain by signal peptidase, a specific protease located on the cisternal face of the endoplasmic reticulum.
See: signal recognition particle.
(18 Nov 1997)
signal peptidase complex A peptide present on proteins that are destined either to be secreted or to be membrane components. It is usually at the N terminus and normally absent from the mature protein. Normally refers to the sequence (ca 20 amino acids) that interacts with signal recognition particle and directs the ribosome to the endoplasmic reticulum where co translational insertion takes place. Could also refer to sequences that direct post translational uptake by organelles. Signal peptides are highly hydrophobic but with some positively charged residues. The signal sequence is normally removed from the growing peptide chain by signal peptidase, a specific protease located on the cisternal face of the endoplasmic reticulum.
See: signal recognition particle.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á